SE0101856D0 - Galanin receptor agonist - Google Patents

Galanin receptor agonist

Info

Publication number
SE0101856D0
SE0101856D0 SE0101856A SE0101856A SE0101856D0 SE 0101856 D0 SE0101856 D0 SE 0101856D0 SE 0101856 A SE0101856 A SE 0101856A SE 0101856 A SE0101856 A SE 0101856A SE 0101856 D0 SE0101856 D0 SE 0101856D0
Authority
SE
Sweden
Prior art keywords
galanin
disorders
ligands
receptor agonist
galanin receptor
Prior art date
Application number
SE0101856A
Other languages
English (en)
Inventor
Uelo Langel
Tamas Bartfai
Kuelliki Saar
Original Assignee
Uelo Langel
Tamas Bartfai
Kuelliki Saar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uelo Langel, Tamas Bartfai, Kuelliki Saar filed Critical Uelo Langel
Priority to SE0101856A priority Critical patent/SE0101856D0/sv
Publication of SE0101856D0 publication Critical patent/SE0101856D0/sv
Priority to US10/155,376 priority patent/US6747060B2/en
Priority to PCT/SE2002/001002 priority patent/WO2002096934A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE0101856A 2001-05-25 2001-05-25 Galanin receptor agonist SE0101856D0 (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE0101856A SE0101856D0 (sv) 2001-05-25 2001-05-25 Galanin receptor agonist
US10/155,376 US6747060B2 (en) 2001-05-25 2002-05-24 Non-natural galanin receptor ligands
PCT/SE2002/001002 WO2002096934A1 (en) 2001-05-25 2002-05-24 Non-natural galanin receptor ligands

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0101856A SE0101856D0 (sv) 2001-05-25 2001-05-25 Galanin receptor agonist

Publications (1)

Publication Number Publication Date
SE0101856D0 true SE0101856D0 (sv) 2001-05-25

Family

ID=20284249

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0101856A SE0101856D0 (sv) 2001-05-25 2001-05-25 Galanin receptor agonist

Country Status (2)

Country Link
US (1) US6747060B2 (sv)
SE (1) SE0101856D0 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006004841A2 (en) * 2004-06-29 2006-01-12 The Scripps Research Institute Galanin agonists
JP2008517930A (ja) * 2004-10-21 2008-05-29 トランス テック ファーマ,インコーポレイテッド GalR1のアゴニストとしてのビススルホンアミド化合物、組成物、及び使用法
CA2671539A1 (en) 2005-12-01 2007-06-07 Flinders Technologies Pty Ltd Methods and compositions for preventing and/or treating pancreatitis
WO2009033748A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of osteostatin, alone or in combination with thymopentin, as a therapeutic agent

Also Published As

Publication number Publication date
US6747060B2 (en) 2004-06-08
US20030055000A1 (en) 2003-03-20

Similar Documents

Publication Publication Date Title
Sandall et al. A novel α-conotoxin identified by gene sequencing is active in suppressing the vascular response to selective stimulation of sensory nerves in vivo
MY139296A (en) CRYSTALLINE ß2 ADRENERGIC RECEPTOR AGONIST
TW200510277A (en) Crystalline form of β2-adrenergic receptor agonist
MY138220A (en) ARYL ANILINE ß2 ADRENERGIC RECEPTOR AGONISTS
IL180603A (en) 3,4-Dihydro-1 H- Naphthalanones which are glucocorticoid receptor modulators
DE602004023946D1 (de) Kombinationen aus einem arylanilin-beta-2-adrenozeptor-agonisten und einem corticosteroid
PT1235787E (pt) Receptores agonistas beta2 adrenergicos
DK0975595T3 (da) Kokainanaloger
DE60231341D1 (de) Fluor- und sulfonylaminohaltige, 3,6-disubstituierptorantagonisten
MXPA03007513A (es) Compuestos heteropoliciclicos y su uso como antagonistas del receptor metabotropico de glutamato.
DOP2004000888A (es) 2-hidroxi-3-diaminoalcanos de benzamida (benzamide 2-hydroxy-3-diaminoalkanes
EP1982713A3 (en) Substituted benzoxazoles and analogues as estrogenic agents for the treatment of inflammatory bowel diseases
WO2007012661A8 (fr) Composes derives d'hydantoïne et leur utilisation en tant qu'antagonistes de mchr-1
GEP20115213B (en) Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists
JP2003520850A (ja) 新規なメラノコルチン受容体作動薬および拮抗薬
UA86621C2 (ru) Антагонисты рецептора глюкагона, их получение и терапевтическое применение
IS7649A (is) Bensamíð- eða fenýlasetamíðafleiður sem nýtast vel sem viðtakabindlar skjaldkirtilshormóns
WO2005030678A3 (en) AMINO-SUBSTITUTED ETHYLAMINO β2 ADRENERGIC RECEPTOR AGONISTS
EP1398029A8 (en) NR3B1 nuclear receptor binding 3-substituted pyrazole derivatives
MX2007007472A (es) Derivados de triazolona, tetrazolona e imidazolona para uso como antagonista del adrenorreceptor alfa-2c.
EP1741792A4 (en) NEW LIGAND OF A G-PROTEIN-CONJUGATED RECEPTOR PROTEIN AND USE THEREOF
MY138547A (en) N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
EA200501122A1 (ru) Замещенные алкиламидопиперидины
SE0101856D0 (sv) Galanin receptor agonist
AU2003277280A8 (en) Biphenyls and fluorenes as imaging agents in alzheimer's disease